The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,754.00
Bid: 1,753.50
Ask: 1,754.00
Change: -2.00 (-0.11%)
Spread: 0.50 (0.029%)
Open: 1,743.50
High: 1,759.00
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Santarus, Sequenom, Durect, Tremor, Gap

Fri, 08th Nov 2013 12:44

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Nov 8 (Reuters) - U.S. stock index futures advanced onFriday, indicating the S&P 500 will rebound from its biggestdaily decline since late August, ahead of a key report on thelabor market. S&P 500 futures was up 3.6 points, DowJones industrial average futures was up 11 points andNasdaq 100 futures was up 12 points.

** TWITTER INC, Thursday close $44.90, up 0.8 pctpremarket

The micro-blogging site's shares jumped 73 percent in afrenzied trading debut that drove the seven-year-old company'smarket value to around $25 billion and evoked the heady days ofthe dot-com bubble.

** SANTARUS INC, Thursday close $, up 37 pct aftermarket

** SALIX PHARMACEUTICALS LTD, Thursday close$71.31, up 9.3 pct after market

Salix said it will buy Santarus for about $2.6 billion,gaining two new gastroenterology drugs to strengthen its leadingpresence in that market.

** SEQUENOM INC, Thursday close $1.70, up 23 pctafter market

The genetic testing company reported a smaller-than-expectedthird-quarter loss on Thursday due to higher sales of itsprenatal test designed to detect fetal chromosomalabnormalities.

** DURECT CORP, Thursday close $1.54, down 20percent after market

The drugmaker said it is offering shares in an underwrittenpublic offering. The company had about 102 million sharesoutstanding as of Thursday.

** INSULET CORP, Thursday close $37.05, down 8 pctafter market

The medical device maker reported a muchbigger-than-expected third-quarter loss on Thursday as operatingexpenses rose due to the settlement of a patent lawsuit withMedtronic Inc and the launch of a version of its insulinmanagement system OmniPod.

** PRICELINE.COM INC, Thursday close $1022.89, up1.6 pct premarket

The online travel agency known for its name-your-own priceauction, posted a higher-than-expected quarterly profit onThursday as bookings increased.

** TREMOR VIDEO INC, Thursday close $9.26, down 30pct after market

The online video advertising provider reportedlower-than-expected third-quarter results on Thursday and cutits revenue forecast for 2013. Canaccord Genuitycuts its rating on the stock to "hold" from "buy" and its pricetarget by $3.50 to $9.

* CHEMOCENTRYX INC, Thursday close $4.67, up 7 pctpremarket

The company reported a smaller-than-expected quarterly lossdue to lower expenses and higher revenue from its partnerGlaxoSmithKline Plc, which is funding Chemocentryx drugto treat a disease that causes inflammation of blood vessels inthe kidney.

** WALT DISNEY CO, Thursday close $67.15

The company reported a 12 percent gain in profit that beatWall Street expectations, lifted by higher visitor spending atU.S. theme parks, increased consumer product sales and itssummer animated movie hit "Monsters University." Shares ofDisney, which have gained nearly 35 percent this year, slipped1.8 percent in after-hours trading to $65.94.

** MOLYCORP INC, Thursday close $4.76

The rare earths producer has seen demand and prices for itsproducts rise from their second-quarter lows, the company'schief executive said on Thursday, although the company reporteda wider third-quarter loss.

** BLACKBERRY LTD , Thursday close $6.5

The company will pay its new interim CEO a base salary of $1million, a bonus of up to twice that amount as well as stockawards potentially worth some $85 million, in the hopes ofturning around Canada's most prominent technology company.

** COCA-COLA CO, Thursday close $40.05

The company said it will invest over $4 billion in China andbuild new plants between 2015 and 2017, to counter competitionwhich is chipping away at its share of the country's 421 billionyuan ($69.12 billion) soft drinks market.

** PIXELWORKS INC, Thursday close $4.39, down 8.8pct after market

The digital display chip maker's third-quarter results camein below analysts' expectations on Thursday due to lower chiprevenue.

** GROUPON INC,Thursday close $9.50, up 1.3 pctpremarket

The daily coupon website reported a third-quarter profitthat beat analysts' estimates as strong growth in North Americahelped offset a decline in international revenue.

** SPROUTS FARMERS MARKET INC, Thursday close$46.58, down 4.8 pct after market

The retailer of natural and organic foods on Thursday saidaffiliates of Apollo Global Management LLC, and certain otherstockholders, will sell up to 22.5 million shares in a secondaryoffering.

** AMARIN CORP, Thursday close $1.41, up 6.3 pctafter market

The drugmaker reported a smaller-than-expected third-quarterloss on Thursday as sales of its fish-oil drug Vascepa, whichlowers a type of blood fat, jumped 52 percent from the secondquarter. Total prescriptions for Vascepa were up 58 percent fromthe preceding quarter, Amarin said in a statement.

** FIREEYE INC, Thursday close $38.03, up 9 pctafter market

The technology firm that helps companies fend off cyberattacks, gave a revenue outlook for 2014 that came in ahead ofWall Street forecasts as it posted results for the first timesince it went public in September in one of this year's hottestIPOs.

** GAP INC, Thursday close $37.75, up 8 pct aftermarket

The apparel chain's October same-store sales rose 4 percent,well ahead of the analysts' average estimate of 0.1 percent.

** ARENA PHARMACEUTICALS INC, Thursday close $4.08,up 5 pct after market

The company said Japanese drugmaker Eisai Co Ltd will market its diet drug in most markets worldwide as part ofan expanded agreement, under which the companies will alsodevelop the drug for other indications.

** TALISMAN ENERGY INC Thursday close $11.71

The company said it would sell a stake in some ofits natural gas assets in British Columbia's Montney field toMalaysia-controlled Progress Energy Canada Ltd for C$1.5 billion($1.44 billion) as it restructures global operations.

** JOHNSON & JOHNSON, Thursday close $92.69

Healthcare conglomerate Danaher Corp DHR.N has teamed upwith Blackstone Group LP BX.N to bid for the company'sdiagnostics unit, which makes blood screening equipment andlaboratory blood tests and could fetch more than $4 billion,according to people familiar with the matter.

** NVIDIA CORP, Thursday close $14.54, up 2 pctafter market

The graphics chipmaker gave a revenue forecast for thecurrent quarter that was shy of Wall Street's expectations asthe company faces tough competition in tablets and a slowpersonal computer market.

** GENCO SHIPPING AND TRADING LTD, Thursday close$2.66, down 2.2 pct after market

Analysts at Wells Fargo Securities said the dry bulkshipper, which has short-term debt of $1.5 billion, was likelyto breach its debt agreements. "It remains increasingly unlikelythat Genco Shipping will be able to maintain covenant compliancethrough March 31, 2014," analyst Michael Webber said.

** COSTA INC, Thursday close $19.98

Essilor International said it would buy Costa, amaker of premium sport sunglasses, in a $270 million deal thatwould help the French company tap into the growing prescriptionsun lens market.

(Compiled by Natalie Grover; Editing by Don Sebastian)

More News
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.